effects [qlco]
Anti-Hypertensive Agents [phsu]
alpha blockers [phsu]
receptor [aapp, rcpt]
Beta [plnt]
Angiotensin-Converting Enzyme Inhibitors [phsu]
Angiotensin Receptor [aapp, rcpt]
Calcium Channel Blockers [phsu]
Oxidative Stress [comd]
free oxygen radicals [bacs]
Insufficiency [ftcn]
Antioxidant [phsu]
Enzymes [enzy, orch]
pathogenesis [ftcn]
Hypertension [dsyn]
Trace Elements [bacs, elii]
function [phsf]
Antioxidant [phsu]
Enzymes [enzy, orch]
Antioxidant [phsu]
System [ftcn]
Trace Elements [bacs, elii]
investigated [ftcn]
Including [ftcn]
Hypertension [dsyn]
Subject [grup]
investigated [ftcn]
Whole [qnco]
Patients [podg]
Objective [inpr]
Present [qnco]
Study [mnob]
investigate [ftcn]
System [ftcn]
Trace Elements [bacs, elii]
hypertensive [fndg]
Patients [podg]
GIVEN [cnce]
anti hypertensive [phsu]
therapy [ftcn]
Methods [inpr]
Examined [fndg]
Malondialdehyde [orch]
superoxide dismutase activity [moft]
Copper [bacs, elii, phsu]
Zinc level [lbpr]
Plasma [bdsu]
Patients [podg]
Hypertension [dsyn]
Healthy Control [qlco]
Patients [podg]
Hypertension [dsyn]
Plasma [bdsu]
Malondialdehyde [orch]
Plasma [bdsu]
superoxide dismutase activity [moft]
Patients [podg]
Hypertension [dsyn]
Plasma zinc level [lbpr]
Plasma [bdsu]
copper levels [lbtr]
Patients [podg]
Hypertension [dsyn]
plasma lipid [lbpr]
Oxidative [ftcn]
State [geoa]
Five [qnco]
Treatment given [topp]
Group [idcn]
anti hypertensive drug [phsu]
therapy [ftcn]
treatment [ftcn]
Conclusions [idcn]
Clinical Study [resa]
Angiotensin-Converting Enzyme Inhibitors [phsu]
Angiotensin Receptor Blockers [phsu]
effects [qlco]
Oxidative Stress [comd]
Essential Hypertension [dsyn]
Step [cnce]
Managing [ocac]
Improvement [cnce]
endothelial dysfunction [dsyn]
Calcium Channel Blockers [phsu]
Beta-Blockers [phsu]
alpha blockers [phsu]
receptor [aapp, rcpt]
Anti-Oxidant Effects [phsf]
In Vitro [inpr]
condition [dsyn]
effects [qlco]
Clinical Study [resa]
